Short answer
REGENXBIO Inc. (RGNX) filed an 8-K current report with the SEC on October 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Kenneth T. Mills resigning as director effective October 21, 2026 to lead another company.
REGENXBIO Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Kenneth T. Mills resigning as director effective October 21, 2026 to lead another company
- Departure unrelated to disagreements, reducing apparent governance or strategic disruption risk
- George Migausky appointed independent Chairman, strengthening board independence
- Daniel Tassé relinquishing Lead Independent Director role but remaining on the Board
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other REGENXBIO Inc. 8-K filings
Get the next RGNX 8-K as it lands
Follow RGNX for push alerts, or ask the research agent what this filing means.